Artesunate 400mg Mefloquine 500mg Tablets

Artesunate mefloquine tablet
  • Dosage: 400mg artesunate + 500mg mefloquine
  • Packaging: 6 tablets/blister*10/box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameArtesunate + Mefloquine Tablets (Artesunate 400mg + Mefloquine 500mg Combination Tablets)
SpecificationEach tablet contains: Artesunate 400mg + Mefloquine 500mg
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientArtesunate + Mefloquine (mefloquine hydrochloride)
Pharmacological ClassAntimalarial / Artemisinin Combination Therapy (ACT)
Route of AdministrationOral administration (swallowed whole with water; take with food or milk to enhance absorption and reduce gastrointestinal effects).
PackagingBlister pack (PVC-Alu), typically 12 tablets per box (3 treatment courses of 4 tablets each)
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep blister pack sealed until use. Do not freeze.
Shelf Life36 months (unopened)

Product Overview

Artesunate + Mefloquine Tablets is an oral antimalarial combination preparation containing two active ingredients: Artesunate 400mg and Mefloquine 500mg per tablet. This is an Artemisinin Combination Therapy (ACT), a class of antimalarial medications used for the treatment of uncomplicated Plasmodium falciparum malaria. The combination of two antimalarial agents with different mechanisms of action and pharmacokinetic profiles is designed to enhance efficacy, reduce the risk of resistance development, and shorten the treatment duration.

Artesunate 400mg Mefloquine 500mg Tablets: What the Published Guidance Says

Artemisinin-based combination therapy is the WHO-recommended backbone of falciparum malaria treatment.

Artesunate 400mg Mefloquine 500mg Tablets sits in the Malaria & ACTs range. The notes below are the ones that most often change a specification, a label or a tender submission.

  • ACT is the treatment of choice in all trimesters For uncomplicated P. falciparum malaria, MSF medical guidelines state the treatment of choice in all trimesters is an artemisinin-based combination therapy taken for three days. Co-formulated and co-blistered regimens are both described, including artemether/lumefantrine 20/120 mg and 80/480 mg, artesunate/amodiaquine, artesunate/mefloquine and dihydroartemisinin/piperaquine. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
  • The ACT combinations and their strengths are specified on the WHO Model List Section 6.5.3.1 of the 24th WHO Model List (2025) specifies the curative antimalarials, including artemether + lumefantrine tablet 20 mg + 120 mg and a dispersible tablet, artesunate + amodiaquine, artesunate + mefloquine, artesunate + pyronaridine as granules and tablets, dihydroartemisinin + piperaquine across four tablet strengths, and artesunate co-packaged with sulfadoxine + pyrimethamine. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
  • One combination to handle with care MSF notes that the artesunate + sulfadoxine/pyrimethamine combination is contraindicated in HIV-infected women taking co-trimoxazole preventive therapy, and that artesunate/mefloquine should not be used where neurological signs developed during the acute phase. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Artesunate 400mg Mefloquine 500mg Tablets. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Artesunate 400mg Mefloquine 500mg Tablets — Supply Parameters

Product NameArtesunate + Mefloquine Tablets (Artesunate 400mg + Mefloquine 500mg Combination Tablets)
SpecificationEach tablet contains: Artesunate 400mg + Mefloquine 500mg
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientArtesunate + Mefloquine (mefloquine hydrochloride)
Pharmacological ClassAntimalarial / Artemisinin Combination Therapy (ACT)
Route of AdministrationOral administration (swallowed whole with water; take with food or milk to enhance absorption and reduce gastrointestinal effects).
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep blister pack sealed until use. Do not freeze.
Therapeutic groupMalaria & ACTs — Malaria & ACTs
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Chloroquine Phosphate 500mg Tablets, Dihydroartemisinin 40mg + Piperaquine 320mg Tablets, Sulfadoxine/Pyrimethamine 175mg + Amodiaquine 75mg, Sulfadoxine Pyrimethamine 175mg + Dihydroartemisinin 60mg, Artesunate 200mg + Amodiaquine 600mg Tablets, Artemether Lumefantrine 80/480mg Tablets, Artesunate Suppositories 100mg, Artemether 80mg Injection.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Artesunate 400mg Mefloquine 500mg Tablets is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: Blister pack (PVC-Alu), typically 12 tablets per box (3 treatment courses of 4 tablets each). Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep blister pack sealed until use. Do not freeze..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Documents for Artesunate 400mg Mefloquine 500mg Tablets are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

The context for Artesunate 400mg Mefloquine 500mg Tablets is its place among ACT regimens named in the WHO Model List of Essential Medicines. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Frequently Asked Questions

What pack size is available for Artesunate 400mg Mefloquine 500mg Tablets?

This presentation is normally supplied as Blister pack (PVC-Alu), typically 12 tablets per box (3 treatment courses of 4 tablets each). Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of Artesunate 400mg Mefloquine 500mg Tablets?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Artesunate 400mg Mefloquine 500mg Tablets support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

What is the difference between artesunate and artemether for injection?

Artesunate is the WHO drug of choice for severe malaria and may be given intravenously or intramuscularly at 2.4 mg/kg. Artemether is an alternative given intramuscularly at 3.2 mg/kg on admission then 1.6 mg/kg daily, and must never be given intravenously.

Which ACT combinations appear on the WHO Model List?

The 24th List (2025) specifies artemether + lumefantrine, artesunate + amodiaquine, artesunate + mefloquine, artesunate + pyronaridine, dihydroartemisinin + piperaquine, artesunate co-packaged with sulfadoxine + pyrimethamine, and chloroquine restricted to P. vivax.

Related Malaria & ACTs Products

Browse the full Malaria & ACTs range; all Tablets; the complete product catalogue.

Request a Quotation for Artesunate 400mg Mefloquine 500mg Tablets

For tenders and programme supply, send the line item, pack size, quantity and destination for Artesunate 400mg Mefloquine 500mg Tablets 400mg. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products